Patient and public involvement: how much do we spend and what are the benefits?

被引:59
|
作者
Pizzo, Elena [1 ]
Doyle, Cathal [2 ]
Matthews, Rachel [3 ]
Barlow, James [4 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Business, London SW7 2AZ, England
[2] Chelsea & Westminster Hosp NHS Fdn Trust, NIHR CLAHRC Northwest London, Evaluat, London, England
[3] Chelsea & Westminster Hosp NHS Fdn Trust, NIHR CLAHRC Northwest London, Patient & Publ Involvement, London, England
[4] Univ London Imperial Coll Sci Technol & Med, Sch Business, Technol & Innovat Management, London SW7 2AZ, England
关键词
benefits; costs; engagement; involvement; patient and public involvement; public; SHARED DECISION-MAKING; HEALTH-CARE; CONSUMER INVOLVEMENT; BREAST-CANCER; PARTICIPATION; IMPACT; POLICY; COSTS; STATE;
D O I
10.1111/hex.12204
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and objectives Patient and public involvement (PPI) is seen as a way of helping to shape health policy and ensure a patient-focused health-care system. While evidence indicates that PPI can improve health-care decision making, it also consumes monetary and non-monetary resources. Given the financial climate, it is important to start thinking about the costs and benefits of PPI and how to evaluate it in economic terms. Design We conducted a literature review to assess the potential benefits and costs of involvement and the challenges in carrying out an economic evaluation of PPI. Results The benefits of PPI include effects on the design of new projects or services, on NHS governance, on research design and implementation and on citizenship and equity. Economic evaluation of PPI activities is limited. The lack of an appropriate analytical framework, data recording and understanding of the potential costs and benefits of PPI, especially from participants' perspectives, represent serious constraints on the full evaluation of PPI. Conclusions By recognizing the value of PPI, health-care providers and commissioners can embed it more effectively within their organizations. Better knowledge of costs may prompt organizations to effectively plan, execute, evaluate and target resources. This should increase the likelihood of more meaningful activity, avoid tokenism and enhance organizational efficiency and reputation.
引用
收藏
页码:1918 / 1926
页数:9
相关论文
共 50 条
  • [41] Cost-Effectiveness Model for Youth EFNEP Programs: What Do We Measure and How Do We Do It?
    Serrano, Elena
    McFerren, Mary
    Lambur, Michael
    Ellerbock, Michael
    Hosig, Kathy
    Franz, Nancy
    Townsend, Marilyn
    Baker, Susan
    Muennig, Peter
    Davis, George
    JOURNAL OF NUTRITION EDUCATION AND BEHAVIOR, 2011, 43 (04) : 295 - 302
  • [42] The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results
    Kruijshaar, M. E.
    Pimpin, L.
    Abubakar, I.
    Rice, B.
    Delpech, V.
    Drumright, L. N.
    Hollo, V.
    Huitric, E.
    van de Laar, M.
    Amato-Gauci, A.
    Manissero, D.
    Kodmon, C.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (06) : 1374 - 1381
  • [43] Primary neuroendocrine breast cancer, how much do we know so far?
    Alkaied, Homam
    Harris, Kassem
    Azab, Basem
    Dai, Qun
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2613 - 2618
  • [44] How Do We Talk About the Physician-Patient Relationship? What the Nonempirical Literature Tells Us
    Hoff, Timothy
    Collinson, Grace E.
    MEDICAL CARE RESEARCH AND REVIEW, 2017, 74 (03) : 251 - 285
  • [45] Health System Efficiency and eHealth Interoperability - How Much Interoperability Do We Need?
    Stroetmann, Karl A.
    NEW PERSPECTIVES IN INFORMATION SYSTEMS AND TECHNOLOGIES, VOL 2, 2014, 276 : 395 - 406
  • [46] How much do we know about the breeding biology of bird species in the world?
    Xiao, Hongtao
    Hu, Yigang
    Lang, Zedong
    Fang, Bohao
    Guo, Weibin
    Zhang, Qi
    Pan, Xuan
    Lu, Xin
    JOURNAL OF AVIAN BIOLOGY, 2017, 48 (04) : 513 - 518
  • [47] Primary neuroendocrine breast cancer, how much do we know so far?
    Homam Alkaied
    Kassem Harris
    Basem Azab
    Qun Dai
    Medical Oncology, 2012, 29 : 2613 - 2618
  • [48] How do we tell what we do? We can move from the traditional pedagogical report to records that recover the complexity of what happens in the classroom
    Torrealba, Maria Teresa
    Gulman, Paula Sofia
    Duri, Rocio
    FORO EDUCACIONAL, 2024, (42): : 111 - 143
  • [49] Identifying and estimating the effects of unconventional monetary policy: How to do it and what have we learned?
    Rossi, Barbara
    ECONOMETRICS JOURNAL, 2021, 24 (01) : C1 - C32
  • [50] Revisiting Shadow IT research: What we already know, what we still need to know, and how do we get there?
    Magunduni, Joshua
    Chigona, Wallace
    2018 CONFERENCE ON INFORMATION COMMUNICATIONS TECHNOLOGY AND SOCIETY (ICTAS), 2018,